CHM.AX up 50% pre-market 07 Jan 2026: volume 18.91M signals active trading ahead

CHM.AX stock opened pre-market on 07 Jan 2026 with a 50.00% intraday move to A$0.003, driven by heavy flow of 18,910,051 shares. This spike lifted volume to 2.22x the average and moved the price off a A$0.002 open. Traders should note the trade is concentrated and the company remains a clinical-stage biotechnology name listed on the ASX in Australia, with ongoing phase I trials that underpin longer-term value.